← Home
the stock rose after the drugmaker posted quarterly earnings Wednesday that surpassed analysts’ expectations and increased its quarterly dividend
+5.04% closed: 2025-02-05
AbbVie Inc.’s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to offset declining sales of its blockbuster Humira
+4.49% closed: 2025-02-15
Reasons are not apparent
Stock Swings
Price Drops
No drop incidentsPrice Hikes
+5.22% closed: 2024-11-02+5.04% closed: 2025-02-05
AbbVie Inc.’s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to offset declining sales of its blockbuster Humira
+4.49% closed: 2025-02-15
Reasons are not apparent
Wait! There's more — sign up for free or log in